Rémy Duléry, Researcher at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“Honored to speak at the CHIA meeting in Paris on Cellular and Humoral Immunotherapy in Autoimmunity, where I presented on the risk of cancer after CAR T-cell therapy.
The meeting stands out for its high-quality lectures and inspiring discussions, and it was a real pleasure to reconnect with colleagues and friends, especially Zinaida Peric.
Many thanks to Dror Mevorach, Mohamad Mohty, and Arnon Nagler for organizing such a vibrant and forward-looking event.
Gatherings like this show how quickly the field is advancing and the importance of connecting expertise across hematology, immunotherapy, and autoimmunity.”
